ATE440591T1 - Ionophore antibiotische formulierungen - Google Patents

Ionophore antibiotische formulierungen

Info

Publication number
ATE440591T1
ATE440591T1 AT01271212T AT01271212T ATE440591T1 AT E440591 T1 ATE440591 T1 AT E440591T1 AT 01271212 T AT01271212 T AT 01271212T AT 01271212 T AT01271212 T AT 01271212T AT E440591 T1 ATE440591 T1 AT E440591T1
Authority
AT
Austria
Prior art keywords
antibiotic formulations
ionophore antibiotic
ionophore
formulations
antibiotic
Prior art date
Application number
AT01271212T
Other languages
English (en)
Inventor
Kim Agnew
William Hewitt
Craig Hanham
Kevin Purdy
Original Assignee
Eli Lilly & Company Nz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ509092A external-priority patent/NZ509092A/en
Application filed by Eli Lilly & Company Nz Ltd filed Critical Eli Lilly & Company Nz Ltd
Application granted granted Critical
Publication of ATE440591T1 publication Critical patent/ATE440591T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
AT01271212T 2000-12-19 2001-12-18 Ionophore antibiotische formulierungen ATE440591T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ509092A NZ509092A (en) 2000-12-19 2000-12-19 Ionophore antibiotic formulations containing a dispersing agent with the ionophore antibiotic having a mean particle size of less than 20 microns
NZ51418301 2001-09-13
PCT/NZ2001/000290 WO2002049609A1 (en) 2000-12-19 2001-12-18 Ionophore antibiotic formulations

Publications (1)

Publication Number Publication Date
ATE440591T1 true ATE440591T1 (de) 2009-09-15

Family

ID=26652236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271212T ATE440591T1 (de) 2000-12-19 2001-12-18 Ionophore antibiotische formulierungen

Country Status (12)

Country Link
US (2) US20040071782A1 (de)
EP (1) EP1345587B1 (de)
KR (1) KR20030078871A (de)
AR (1) AR031939A1 (de)
AT (1) ATE440591T1 (de)
AU (2) AU2002216503B9 (de)
BR (1) BRPI0116282B1 (de)
CA (1) CA2430791C (de)
DE (1) DE60139712D1 (de)
ES (1) ES2331406T3 (de)
MX (1) MXPA03005512A (de)
WO (1) WO2002049609A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
US9149456B2 (en) * 2008-07-28 2015-10-06 Zoetis Services Llc Laidlomycin compositions and methods
US8415121B2 (en) * 2009-10-05 2013-04-09 Alpharma, Llc Process for the manufacture of laidlomycin
AU2016221774B2 (en) 2015-02-17 2020-09-17 Orotech Nv Solid pharmaceutical dosage form suitable for use as drinking water medication
CA2978016C (en) * 2015-04-28 2019-11-26 Elanco Us Inc. Monensin water dispersible granules by wet granulation
KR102227147B1 (ko) * 2018-08-30 2021-03-12 한국화학연구원 이오노포어를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 보조제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754856A (fr) 1969-08-18 1971-02-15 Hoffmann La Roche Nouveaux antibiotiques
US3829557A (en) 1970-06-12 1974-08-13 Erco Ind Ltd Production of chlorine dioxide
US3839557A (en) * 1972-01-24 1974-10-01 Lilly Co Eli Antibiotics monensin and a204 for improving ruminant feed efficiency
IL70015A0 (en) 1983-10-20 1984-01-31 Koffolk 1949 Ltd Ionophore antibiotic compositions and processes for the preparation thereof
US4746349A (en) * 1986-08-06 1988-05-24 American Cyanamid Company Method and compositions for suppressing the nitrification of ammonium in plant growth medium
ATE264667T1 (de) * 1995-07-14 2004-05-15 Elli Lilly & Co Nz Ltd Formulierungen mit monensin
NZ272574A (en) * 1995-07-14 1999-02-25 Lilly Eli & Co Nz Ltd Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
US6086633A (en) * 1996-10-17 2000-07-11 Eli Lilly And Company Method for preserving animal hides
WO1998016663A1 (en) * 1996-10-17 1998-04-23 Eli Lilly And Company Method for preserving animal hides
US6211185B1 (en) * 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent

Also Published As

Publication number Publication date
MXPA03005512A (es) 2004-10-14
KR20030078871A (ko) 2003-10-08
AU2002216503B2 (en) 2006-04-27
BRPI0116282B1 (pt) 2016-04-19
CA2430791C (en) 2010-02-02
AU2002216503B9 (en) 2006-10-12
EP1345587A1 (de) 2003-09-24
ES2331406T3 (es) 2010-01-04
EP1345587B1 (de) 2009-08-26
AU1650302A (en) 2002-07-01
DE60139712D1 (de) 2009-10-08
AR031939A1 (es) 2003-10-08
US20040071782A1 (en) 2004-04-15
US20090238881A1 (en) 2009-09-24
CA2430791A1 (en) 2002-06-27
WO2002049609A1 (en) 2002-06-27
BR0116282A (pt) 2004-03-02

Similar Documents

Publication Publication Date Title
ATE345350T1 (de) Makrolidantibiotika
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
EP1250025A4 (de) Kopfhörer
EP1267765A4 (de) Antibiotische und pilzbekämpfende mittel
DE10195164T1 (de) Hochgeschwindigkeitsverbindung
PT1303521E (pt) Derivados de tetra-hidro-heterocicloazepinil-pirimidina
DE60139747D1 (de) Walzenachse
DE60143037D1 (de) Gleitlager
DK1280809T3 (da) Antitumorecteinascidinderivater
DK1237408T3 (da) Hæld-på-formuleringer
ATE298332T1 (de) Decahydro-isochinolinderivate
DE60019901D1 (de) Rillenwalzvorrichtung
DE60144464D1 (de) Probenentnehmer
IS6398A (is) Lyfjablöndur
DE60033666D1 (de) Verstärker
AR028602A1 (es) Derivados de pirrol
AR028282A1 (es) Derivados de aminofenil pirimidona
DE60102936D1 (de) Antibakterielle mutiline
DE60109229D1 (de) Tupfer
NO20022985L (no) Substituerte aminometyl-fenyl-cykloheksanderivater
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
DE50100739D1 (de) Drehmaschine
ATE268116T1 (de) Mesotrion-formulierungen
DE50115568D1 (de) Kinnbügel-Kopfhörer
ATE440591T1 (de) Ionophore antibiotische formulierungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties